Blueprint Bio's Series A Round

Blueprint Bio raised a round of funding on June 20, 2016. Investors include Forentis Partners.

Blueprint Bio, founded in 2015, is creating a validated marketplace for biomarker signatures in personalized medicine. The company, which identifies, protects and offers new biological discoveries to …

Articles about Blueprint Bio's Series A Round: